Soporte nutricional en pacientes con enfermedades neurológicas

Soporte nutricional en pacientes con enfermedades neurológicas

Author: María Dolores Ballesteros Pomar

Publisher: Ediciones Díaz de Santos

Published: 2012-09-15

Total Pages: 14

ISBN-13: 8499692699

DOWNLOAD EBOOK

INDICE: Introducción. Enfermedad vascular cerebral: evaluación de la disfagia en el paciente con ictus; soporte nutricional en la enfermedad vascular cerebral. Esclerosis lateral amiotrófica: fisiopatología y diagnóstico; objetivos nutricionales; valoración nutricional específica; dietoterapia; soporte nutricional artificial. Nutrición en la demencia: factores nutricionales implicados en la demencia; soporte nutricional del paciente con demencia. Nutrición en enfermedad de Parkinson. Epilepsia. Resumen. Bibliografía.


Mini Nutritional Assessment (MNA)

Mini Nutritional Assessment (MNA)

Author: Bruno J. Vellas

Publisher: Karger Medical and Scientific Publishers

Published: 1999

Total Pages: 202

ISBN-13: 3805568037

DOWNLOAD EBOOK

This book is the first of a new series which will present the proceedings of the newly established Nestlé Nutrition Workshop Series: Clinical & Performance Programme aimed at adult nutrition. Undernutrition is a common phenomenon in elderly people, and malnutrition reaches significant levels in those being in hospital, nursing homes or home care programs. Consequences of malnutrition often go unrecognised owing to the lack of specific validated instruments to assess nutritional status in frail elderly persons. The Mini Nutritional Assessment (MNA) provides a single, rapid assessment of nutritional status in the elderly of different degrees of independence, allowing the prevalence of protein-energy malnutrition to be determined and to evaluate the efficacy of nutritional intervention and strategies. Easy, quick and economical to perform, it enables staff to check the nutritional status of elderly people when they enter hospitals or institutions and to monitor changes occurring during their stay. Moreover, the MNA is predictive of the cost of care and length of stay in hospital. This publication will be of immense assistance to heads of geriatric teaching units, teachers in nutrition, clinicians general practitioners and dieticians, enabling them to better detect, recognise and start treatment of malnutrition in the elderly.


Rett Disorder and the Developing Brain

Rett Disorder and the Developing Brain

Author: Alison Kerr

Publisher:

Published: 2001

Total Pages: 412

ISBN-13:

DOWNLOAD EBOOK

Rett disorder, first described by Andreas Rett in 1966, is a condition which involves the functions on which intelligence and expression depend. It is probably the most common genetic disorder encountered in profoundly intellectually disabled females. Its many manifestations include epilepsy, scoliosis, nutritional difficulties, and disorders of mood and movement. This book provides an up-to-date account of current research into the disorder at a time when the causative mutations have just been discovered on the MeCP2 gene. The first section of the book presents the clinical signs and the latest research into the genetic, neuro- anatomical and neuro-chemical aspects of Rett disorder. The second section moves on to deal with the neuro-physiological research, concentrating on the autonomic system, which is deeply implicated in the disease mechanisms. The final section of the book examines the behavioural and psychological features of Rett disorder and discusses issues relating to communication. The chapters are written by a distinguished, international team of experts, all currently active in research. The contributions bring our understanding of the Rett disorder right up-to-date, as the study of the condition moves from an era of description into a time when there are real possibilities for beneficial interventions.


The Wernicke-Korsakoff Syndrome and Related Neurologic Disorders Due to Alcoholism and Malnutrition

The Wernicke-Korsakoff Syndrome and Related Neurologic Disorders Due to Alcoholism and Malnutrition

Author: Maurice Victor

Publisher: Davis Publications

Published: 1989

Total Pages: 266

ISBN-13:

DOWNLOAD EBOOK

The major text on Korsakoff's syndrome and Wernicke's encephalopathy. Appearing many years after the first edition in 1971, this revision carries far more clinical experience and allows comment upon nonalcoholic patients--in many of whom the disease was iatrogenic. Much is new: thiamine deficiency and the nervous system, Korsakoff amnesic state, and so-called alcoholic cerebral atrophy. Annotation copyrighted by Book News, Inc., Portland, OR


Growth Hormone Therapy in Pediatrics

Growth Hormone Therapy in Pediatrics

Author: Michael B. Ranke

Publisher: Karger Medical and Scientific Publishers

Published: 2007-01-01

Total Pages: 534

ISBN-13: 3805582560

DOWNLOAD EBOOK

For 20 years, KIGS (Pfizer International Growth Database) has provided an outstanding tool for monitoring the use, efficacy and safety of growth hormone (GH) treatment in children with short stature of varying origin. This volume offers a comprehensive update of the continuing experiences in KIGS and is based on data from more than 50 countries and more than 60,000 patients. International experts analyse in detail the basic auxological characteristics of patients and their response to GH treatment for a broad spectrum of growth disorders. These include idiopathic GH deficiency, organic GH deficiency due to a variety of causes such as congenital malformations and syndromes, genetic disorders or treatment for leukaemia or central nervous system tumours and short stature in children born small for gestational age, specific syndromes and systemic disorders. Each growth disorder is also covered by a review of relevant published data by international experts. KIGS has also established itself as a primary source of information about adverse events during long-term GH treatment in children. The recent analysis of KIGS data has revealed no new adverse drug reactions since the 10-year follow-up. Therefore, treatment with GH seems a low-risk intervention in children and adolescents with various growth disorders. The process of developing disease-specific growth response prediction models has been ongoing in KIGS for many years. The available models are accurate, precise and have a relatively high degree of predictive power, although further predictors of the growth response remain to be identified. The KIGS prediction models can be applied prospectively to new patients, enabling their GH therapy to be better tailored and monitored to achieve optimal growth, safety and cost outcomes. The future of KIGS within the era of evidence-based medicine will continue to depend upon the quality of the data reported. Therefore, the commitment of participating physicians will continue to be a decisive element. The ongoing recognition of the importance of valid safety and efficacy information in the practice of paediatric endocrinology is exemplified by this valuable international collaboration of clinicians and the pharmaceutical community.